NZ613090A - Modified release benzimidazole formulations - Google Patents

Modified release benzimidazole formulations

Info

Publication number
NZ613090A
NZ613090A NZ613090A NZ61309011A NZ613090A NZ 613090 A NZ613090 A NZ 613090A NZ 613090 A NZ613090 A NZ 613090A NZ 61309011 A NZ61309011 A NZ 61309011A NZ 613090 A NZ613090 A NZ 613090A
Authority
NZ
New Zealand
Prior art keywords
modified release
omeprazole
benzimidazole
methacrylic acid
ethyl acrylate
Prior art date
Application number
NZ613090A
Other languages
English (en)
Inventor
Lingam Meka
Srinivasa Almareddy Reddy
Vagisha Sinha
Hitesh Jogia
Srinivas Arutla
Raviraj Pillai
Rahul Sudhakar Gawande
Prasad Vure
Venkateswarlu Vobalaboina
Original Assignee
Reddy’S Lab Inc Dr
Reddy’S Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy’S Lab Inc Dr, Reddy’S Lab Ltd Dr filed Critical Reddy’S Lab Inc Dr
Publication of NZ613090A publication Critical patent/NZ613090A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ613090A 2010-12-29 2011-12-29 Modified release benzimidazole formulations NZ613090A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN4013CH2010 2010-12-29
US201161447759P 2011-03-01 2011-03-01
PCT/US2011/067868 WO2012092486A2 (fr) 2010-12-29 2011-12-29 Formulations de benzimidazole à libération modifiée

Publications (1)

Publication Number Publication Date
NZ613090A true NZ613090A (en) 2015-11-27

Family

ID=46383862

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ613090A NZ613090A (en) 2010-12-29 2011-12-29 Modified release benzimidazole formulations

Country Status (7)

Country Link
EP (1) EP2661260A4 (fr)
CN (1) CN103402501A (fr)
AU (1) AU2011352037A1 (fr)
EA (1) EA201390979A1 (fr)
NZ (1) NZ613090A (fr)
UA (1) UA112855C2 (fr)
WO (1) WO2012092486A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2647472C2 (ru) * 2011-11-02 2018-03-15 Лабораторьос Дель Др. Эстеве, С.А. Фармацевтическая композиция омепразола
EA201500742A1 (ru) * 2013-02-05 2015-12-30 Пердью Фарма Л.П. Защищенные от нецелевого использования фармацевтические композиции
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
WO2014142938A1 (fr) * 2013-03-15 2014-09-18 Aihol Corporation Formulation pharmaceutique contenant un glycosaminoglycane
EP3288556A4 (fr) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Compositions à désintégration par voie orale
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
CN112336696B (zh) * 2020-12-01 2022-08-05 苏州中化药品工业有限公司 一种长效脉冲制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050244497A1 (en) * 1997-11-05 2005-11-03 Wockhardt Limited Delayed delivery system for acid-sensitive drugs
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
JP4541807B2 (ja) * 2004-09-03 2010-09-08 Ｏｋｉセミコンダクタ株式会社 半導体素子保持装置および半導体素子の搬送方法
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
JP2010534721A (ja) * 2007-07-27 2010-11-11 ディポメド，インコーポレイティド パルス型胃滞留性製剤
US20090214599A1 (en) * 2008-02-21 2009-08-27 Agi Therapeutics Plc Proton pump inhibitor formulations, and methods of preparing and using such formulations

Also Published As

Publication number Publication date
EP2661260A2 (fr) 2013-11-13
UA112855C2 (uk) 2016-11-10
WO2012092486A3 (fr) 2012-11-01
EP2661260A4 (fr) 2014-05-14
EA201390979A1 (ru) 2013-12-30
AU2011352037A1 (en) 2013-08-01
WO2012092486A2 (fr) 2012-07-05
CN103402501A (zh) 2013-11-20

Similar Documents

Publication Publication Date Title
NZ613090A (en) Modified release benzimidazole formulations
ECSP13012718A (es) Comprimido de desintegración oral
MX2019013171A (es) Formulaciones muco-adhesivas de liberacion controlada de levodopa y/o esteres de levodopa y sus usos.
WO2010027676A3 (fr) Composition dentaire comprenant un monomère de di(méth)acrylate de biphényle
HRP20171022T1 (hr) Kombinacija oksidacijskog sredstva i fotoaktivatora za liječenje ozljeda
HK1151307A1 (en) (meth) acrylic acid/alkyl(meth) acrylate ester copolymer and cosmetic preparation containing the same ()/()
MY164607A (en) Solid compositions
EP2261201A4 (fr) Composé de (méth)acrylate trifonctionnel et composition polymérisable contenant le composé
MY155242A (en) Antireflective coating compositions
MX2014005514A (es) Formulaciones de pelicula para los dientes.
ZA201101738B (en) (meth)acrylate monomer, polymer, and coating agent
NZ603881A (en) High refractive index, acrylic ophthalmic device materials with reduced glistenings
IL182696A0 (en) New modified release pellet formulations for proton pump inhibitors
MX358873B (es) Recubrimientos abrasivos para composiciones que contienen peroxido.
EP2042523A4 (fr) Copolymère d'acide (méth)acrylique réticulé et électrode de cellule secondaire utilisant ledit copolymère
BRPI0916318A2 (pt) copolímeros em bloco com base em (met) acrilato
BR112017013255A2 (pt) emplastro em gel
TN2011000261A1 (en) Octreotide depot formulation with constantly high exposure levels
EP2554555A4 (fr) Monomère (méth)acrylate d'adamantyle et polymère (méth)acrylique qui contient des motifs répétitifs issus du monomère
WO2008145475A8 (fr) Composition pour l'hygiène buccale
MX344189B (es) Formulaciones de mazindol.
EP2100627A4 (fr) Copolymère de (méth)acrylate, procédé de production de celui-ci et dispositif médical
WO2011131452A3 (fr) Composition
EP3674335A4 (fr) Polymère à base d'ester alkylique d'acide (méth)acrylique et utilisation associée
WO2013072162A3 (fr) Produit servant à la mise en forme temporaire de fibres kératiniques, à base d'une combinaison de polymères filmogènes spécifiques

Legal Events

Date Code Title Description
PSEA Patent sealed
LAPS Patent lapsed